Recombinant MUC13 Monoclonal Antibody (AN301769L)

Citations ({{ citationsPage.numTotal }}) Manual MSDS

Resources

All	Size	Price	Qty
	100μL	$ 320.00	- +
	50μL	$ 211.00	- +

Add to cart

For research use only. Order now, ship in 3 days

Verified Samples	Verified Samples in WB: HT-29 Verified Samples in IF: HepG2
Dilution	WB 1:1000, IHC-P 1:1000-1:5000, ICC/IF 1:50-1:100, FCM 1:1:50-1:100
Isotype	Rabbit IgG
Host	Rabbit
Reactivity	Human
Applications	WB, IHC-P, ICC/IF, FC
Clonality	Monoclonal;Recombinant
Immunogen	A synthetic peptide of human MUC13
Abbre	MUC13
Synonyms	Muc, UNQ, DRCC, DRCC1, RECC, MUC13, UNQ6194, PRO20221, Down-regulated in colon cancer 1
Swissprot	Q9H3R2
Calculated MW	55 kDa
Cellular Localization	Cell membrane and Secreted
Concentration	1 mg/mL
Buffer	PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification Method	Protein A purified
Research Areas	Signal Transduction, Cancer
Clone	C311391
Conjugation	Unconjugated
Storage	Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Shipping	Ice bag
background	Mucin 13 (MUC13) is a high-molecular-weight transmembrane glycoprotein that is frequently and aberrantly expressed in a variety of epithelial carcinomas, including gastric, colorectal, and ovarian cancers. On the basis of the high expression of MUC13 in cancer cells as well as recent laboratory findings suggesting a malignant phenotype of MUC13-transfected cell lines, the oncogenic potential of MUC13 has emerged. The various functional domains of MUC13 may confer oncogenic potential to MUC13. MUC13 exhibits the characteristics suitable as an early marker for cancer screening and presents a promising target for antibody-guided targeted therapy.